Q4 2021 Altimmune Inc Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the Altimmune Inc. Full Year and Q4 Earnings Conference Call. (Operator Instructions) As a reminder, this call is being recorded.
I would now like to introduce your host for today's conference, Rich Eisenstadt, Chief Financial Officer at Altimmune. Rich, you may begin.
Thank you, Jonathan, and good morning, everyone. Thank you for participating in Altimmune's Full Year and Fourth Quarter 2021 Earnings Conference Call. Members of the Altimmune team joining me on the call today are Vipin Garg, our Chief Executive Officer; Scot Roberts, our Chief Scientific Officer; and Scott Harris, our Chief Medical Officer.
Following the prepared remarks, we will hold a question-and-answer session. A press release with our full year and fourth quarter 2021 financial results was issued this morning and can be found on the Investor Relations section of the company's website.
Before we begin, I would like to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |